Bumetanide Derivatives for Hyperhidrosis Therapy - Otolanum AG
Summary
EPO published patent application EP3774763A1 for bumetanide derivatives used in hyperhidrosis therapy. The patent, assigned to Otolanum AG with inventors Thomas Erker and Philipp Schreppel, covers pharmaceutical compositions and methods of treatment. The patent is designated for all 31 European states including Germany, France, the United Kingdom, Italy, and Spain.
What changed
EPO published patent application EP3774763A1 for bumetanide derivatives intended for hyperhidrosis therapy. The patent application, filed by Otolanum AG with inventors Thomas Erker and Philipp Schreppel, covers pharmaceutical compositions comprising bumetanide derivatives for therapeutic use in treating excessive sweating.
For pharmaceutical manufacturers and biotech companies developing diuretic-based therapies, this patent publication establishes intellectual property rights in European markets. Generic drug manufacturers and R&D teams should conduct freedom-to-operate analyses to assess potential patent overlap with existing or planned product development programs.
What to do next
- Review patent claims for freedom to operate
- Monitor for updates
Archived snapshot
Apr 15, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
BUMETANIDE DERIVATIVES FOR THE THERAPY OF HYPERHIDROSIS
Publication EP3774763A1 Kind: A1 Apr 08, 2026
Applicants
Otolanum AG
Inventors
ERKER, Thomas, SCHREPPEL, Philipp
IPC Classifications
C07D 333/18 20060101AFI20191011BHEP C07D 333/34 20060101ALI20191011BHEP C07D 333/40 20060101ALI20191011BHEP C07D 233/84 20060101ALI20191011BHEP C07C 311/18 20060101ALI20191011BHEP C07D 235/08 20060101ALI20191011BHEP C07D 239/38 20060101ALI20191011BHEP C07D 239/80 20060101ALI20191011BHEP C07D 265/30 20060101ALI20191011BHEP C07D 207/09 20060101ALI20191011BHEP C07D 211/34 20060101ALI20191011BHEP C07D 213/34 20060101ALI20191011BHEP A61P 25/00 20060101ALI20191011BHEP A61K 31/445 20060101ALI20191011BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.